Bruggeman, B. S., Gornisiewicz, S., Bacher, R., McGrail, K., Campbell-Thompson, M., Wasserfall, C., . . . Schatz, D. A. (2024, November). Serum exocrine pancreas enzymes are biomarkers of immunotherapy response in new-onset type 1 diabetes. Frontiers in Endocrinology.
Chicagoスタイル(17版)引用形式Bruggeman, Brittany Sorensen, et al. "Serum Exocrine Pancreas Enzymes Are Biomarkers of Immunotherapy Response in New-onset Type 1 Diabetes." Frontiers in Endocrinology Nov. 2024.
MLA(9版)引用形式Bruggeman, Brittany Sorensen, et al. "Serum Exocrine Pancreas Enzymes Are Biomarkers of Immunotherapy Response in New-onset Type 1 Diabetes." Frontiers in Endocrinology, Nov. 2024.
警告: この引用は必ずしも正確ではありません.
